Investor profile
Kurt von Emster
Operator-led, Venture capital & Managing Partner at Abingworth, Board Member at SFJ Pharmaceuticals
Kurt von Emster works as a Managing Partner at Abingworth. The firm's known portfolio counts 13 companies.
Is Kurt von Emster a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Affiliated funds' portfolios
Managing Partner at Abingworth, whose known portfolio counts 13 companies
- Iambic
- Glycomine
- AdvanCell
- Atsena Therapeutics
- Solve Therapeutics
- Addition Therapeutics
- Vaxcyte
- Wugen
- Pathalys Pharma
- R1 Therapeutics
- Antares Therapeutics
- Myricx Bio
- and 1 more
Board Member at SFJ Pharmaceuticals, whose known portfolio counts 2 companies
- PhaseBio Pharmaceuticals
- Nektar Therapeutics
Investor Profile
Kurt von Emster is listed against sector Healthcare, and focus areas Biologics, Biotech, Clinical Trials and Drug Discovery in the database.
Stage-wise, the deals at Abingworth cluster around Growth, Late-Stage and Seed rounds.
What the affiliated firm has backed is the closest available signal on whether Kurt von Emster is worth approaching.
Colleagues
Genghis Lloyd-Harris
Senior Advisor
London, United Kingdom
Diya Malhotra
Principal
London, United Kingdom
Tim Haines
Managing Director
London, United Kingdom
Bali Muralidhar
Global Head of Life Sciences
London, United Kingdom
Vin Miles
Executive Director
Boston, United States
Jayson Punwani
Managing Director
Menlo Park, United States
Andrew Sinclair
Managing Director
Royal Tunbridge Wells, United Kingdom
Lucille Conroy
Principal
United Kingdom
Krishna Polu
Advisor
San Francisco, United States
Marc Cobo
Investor
San Francisco, United States
Ankur Shah
Vice President
New York City, United States
Graham Mills
Principal
London, United Kingdom
Glh Lloyd Harris
Partner
London, United Kingdom
Barbara White
Senior Director
Finksburg, United States
Frequently asked questions
Who is Kurt von Emster?
Kurt von Emster is an operator-led investor and venture capital investor based in Menlo Park, California, United States, listed as Managing Partner at Abingworth. The known portfolio of that firm counts 13 companies. That portfolio belongs to the firm, not to Kurt von Emster personally.
What does Kurt von Emster invest in?
Listed sectors include Healthcare; listed focus areas include Biologics, Biotech, Clinical Trials and Drug Discovery. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Kurt von Emster invest at?
Abingworth appears in Growth, Late-Stage and Seed rounds across its known deals, and Kurt von Emster is listed there as Managing Partner. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Kurt von Emster listed at?
Kurt von Emster is listed as Managing Partner at Abingworth. 14 other people in the database share a firm with Kurt von Emster.
How do I contact Kurt von Emster?
An email address, a phone number and a LinkedIn page are on file for Kurt von Emster. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal